SotagliflozinSotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease

Sponsor:

Alessandro Doria

Code:

NCT06217302

Conditions

Diabetic Nephropathies

Kidney Failure, Chronic

Diabetes Mellitus Type 1

Heart Failure

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Sotagliflozin

Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-08-21. This information was provided to ClinicalTrials.gov by Alessandro Doria on 2026-03-24.